Overview on Clinical Features of Opioid-Induced Hyperalgesia

Opioid-Induced Hyperalgesia

Volumn , Issue , 2016, Pages 21-37

  Angst, Martin S ^a   Chu, Larry F ^a   Clark, J David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85135431826     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420089004-6     Document Type: Chapter

References (50)

1. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006; 104(3): 570-587.
2. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008; 24(6): 479-496.
3. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am 2007; 91(2): 199-211.
4. Simonnet G, Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport 2003; 14(1): 1-7.
5. Ossipov MH, Lai J, King T, et al. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 2005; 80(2-3): 319-324.
6. Fist MB, Frances A, Pincus HA. DSM-IV-TR Guidbook: The Essential Companion to the Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington: American Psychiatric Publishing, Inc., 2004: 153-155.
7. Himmelsbach CK. The morphine abstinence syndrome, its nature and treatment. Ann Intern Med 1941; 15: 829-839.
8. Compton MA. Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J Pain Symptom Manage 1994; 9(7): 462-473.
9. Compton P, Charuvastra VC, Kintaudi K, et al. Pain responses in methadonemaintained opioid abusers. J Pain Symptom Manage 2000; 20(4): 237-245.
10. Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend 2001; 63(2): 139-146.
11. Doverty M, Somogyi AA, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 2001; 93(2): 155-163.
12. Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain 2001; 90(1-2): 91-96.
13. Dyer KR, Foster DJ, White JM, et al. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships. Clin Pharmacol Ther 1999; 65(6): 685-694.
14. Schall U, Katta T, Pries E, et al. Pain perception of intravenous heroin users on maintenance therapy with levomethadone. Pharmacopsychiatry 1996; 29(5): 176-179.
15. Rainville P, Feine JS, Bushnell MC, et al. A psychophysical comparison of sensory and affective responses to four modalities of experimental pain. Somatosens Mot Res 1992; 9: 265-277.
16. Pud D, Cohen D, Lawental E, et al. Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 2006; 82(3): 218-223.
17. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 2006; 7(1): 43-48.
18. Ram KC, Eisenberg E, Haddad M, et al. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain-new perspective of opioid-induced hyperalgesia. Pain 2008; 139(2): 431-438.
19. Hay JL, White JM, Bochner F, et al. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain 2009; 10: 316-322.
20. Reznikov I, Pud D, Eisenberg E. Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. Br J Clin Pharmacol 2005; 60(3): 311-318.
21. Fillingim RB, Doleys DM, Edwards RR, et al. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine 2003; 28(2): 143-150.
22. Cohen SP, Christo PJ, Wang S, et al. The effect of opioid dose and treatment duration on the perception of a painful standardized clinical stimulus. Reg Anesth Pain Med 2008; 33(3): 199-206.
23. Younger J, Barelka P, Carroll I, et al. Reduced cold pain tolerance in chronic pain patients following opioid detoxification. Pain Med 2008; 9(8): 1158-1163.
24. Compton P, Athanasos P, Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J Pain 2003; 4(9): 511-519.
25. Chia YY, Chow LH, Hung CC, et al. Gender and pain upon movement are associated with the requirements for postoperative patient-controlled iv analgesia: a prospective survey of 2, 298 Chinese patients. Can J Anaesth 2002; 49(3): 249-255.
26. Cooper DW, Lindsay SL, Ryall DM, et al. Does intrathecal fentanyl produce acute cross-tolerance to i.v. morphine? Br J Anaesth 1997; 78(3): 311-313.
27. Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93: 409-417.
28. Joly V, Richebe P, Guignard B, et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 2005; 103(1): 147-155.
29. Crawford MW, Hickey C, Zaarour C, et al. Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery. Anesth Analg 2006; 102(6): 1662-1667.
30. Chia YY, Liu K, Wang JJ, et al. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth 1999; 46: 872-877.
31. Cortinez LI, Brandes V, Munoz HR, et al. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001; 87(6): 866-869.
32. Lee LH, Irwin MG, Lui SK. Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide. Anesthesiology 2005; 102(2): 398-402.
33. Angst MS, Koppert W, Pahl I, et al. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003; 106: 49-57.
34. Hood DD, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003; 97(3): 810-815.
35. Koppert W, Sittl R, Scheuber K, et al. Differential modulation of remifentanilinduced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003; 99(1): 152-159.
36. Gan TJ, Ginsberg B, Glass PS, et al. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 1997; 87(5): 1075-1081.
37. Joshi GP, Duffy L, Chehade J, et al. Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patientcontrolled analgesia. Anesthesiology 1999; 90(4): 1007-1011.
38. Cepeda MS, Africano JM, Manrique AM, et al. The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period. Pain 2002; 96(1-2): 73-79.
39. Cepeda MS, Alvarez H, Morales O, et al. Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects. Pain 2004; 107(1-2): 41-46.
40. Bijur PE, Schechter C, Esses D, et al. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients. J Pain 2006; 7(2): 75-81.
41. Yeh YC, Lin TF, Wang CH, et al. Effect of combining ultralow-dose naloxone with morphine in intravenous patient-controlled analgesia: the cut-off ratio of naloxone to morphine for antiemesis after gynecologic surgery. J Formos Med Assoc 2008; 107(6): 478-484.
42. Webster LR, Butera PG, Moran LV, et al. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain. J Pain 2006; 7(12): 937-946.
43. La Vincente SF, White JM, Somogyi AA, et al. Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects. Clin Pharmacol Ther 2008; 83(1): 144-152.
44. Vorobeychik Y, Chen L, Bush MC, et al. Improved opioid analgesic effect following opioid dose reduction. Pain Med 2008; 9: 724-727.
45. Wilson GR, Reisfield GM. Morphine hyperalgesia: a case report. Am J Hosp Palliat Care 2003; 20: 459-461.
46. Guntz E, Talla G, Roman A, et al. Opioid-induced hyperalgesia. Eur J Anaesthesiol 2007; 24: 205-207.
47. Carroll IR, Angst MS, Clark JD. Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med 2004; 29(6): 576-591.
48. de Leon-Casasola OA, Lema MJ. Epidural bupivacaine/sufentanil therapy for postoperative pain control in patients tolerant to opioid and unresponsive to epidural bupivacaine/morphine. Anesthesiology 1994; 80(2): 303-309.
49. Rapp SE, Ready LB, Nessly ML. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain 1995; 61(2): 195-201.
50. De Kock M, Lavand’homme P, Waterloos H. ‘Balanced analgesia’ in the perioperative period: is there a place for ketamine? Pain 2001; 92(3): 373-380.